Program

Program Details

October 12 (Wed)

Time Program Speaker Affilliation
08:00~09:00 Registration
09:00~09:30 Opening Ceremony
PL 1 : Continued success of Xcopri development: NDA, subsequent development and commercialization
09:30~10:00 Plenary Lecture 1 Chair : In-Jin Jang
09:30~10:00 Continued success of XCOPRI® development: NDA, subsequent development and commercialization Jeong-Woo Cho SK Biopharmaceuticals Co., Ltd.
10:00~10:30 Coffee Break
PS 1 Talkshow: Creating global success of drug development in extremely competitive environment
10:30~12:00 Plenary Session 1 Chair : Hanlim Moon,
Hyunsang Muk
10:30~12:00 PS 1 Talkshow: Creating global success of drug development in extremely competitive environment - - -
10:30~12:00 ┗━ Main Panel : Byoungjun Bae(KoNECT) / Panel : Healthcare Discovery - Daekwon Kim(Voronoi), Branden Ryu(BIORCHESTRA)
10:30~12:00 ┗━ Panel : Clinical Development - Seung-Jae Baek(Hanmi Pharm Co. Ltd) , Se-Woong Oh(Yuhan Corporation) / Commercial - Geun-Seog Song(HK inno.N Corp.), Hyeokjae Lee(Celltrion)
12:00~13:30 Lunch
S1 : Patient-Centric Drug Development & S4 : Drug Delivery to the Target Tissue
13:30~15:00 S1: Patient-Centric Drug Development Chair : BG Rhee,
Yu-Kyeong Hwang
13:30~13:50 Patient-Centric CAR-T Development Dong-Hyuk Jeon CUROCELL
13:50~14:10 Targeting CaV3.1 gene for treating brain disorders Daesoo Kim KAIST
14:10~14:30 Genetic Medicine with Non-viral Delivery Technology Yoonchul Shin GenEdit
14:30~14:50 Open Discussion
14:50~15:00 Q&A
15:00~15:30 Coffee Break
15:30~17:00 S4: Drug Delivery to the Target Tissue Chair : Jinsan Yoo,
Jong-Seo Lee
15:30~15:50 Overcoming the Blood-Brain Barrier for RNA therapeutics Branden Ryu BIORCHESTRA Co., Ltd.
15:50~16:10 Brain Somatic Mutations as RNA Therapeutic Targets in Neurological Disorders Jeong-Ho Lee SoVarGen/KAIST
16:10~16:30 BBB Shuttle by Aptamer Technology Daekyun Lee Apatmaer Sciences
16:30~17:00 Gene Therapy Platform Technologies for the Innovation Hyun-Bae Jie Levatio Therapeutics
17:00~17:30 Open Discussion
S2 : Creating Comprehensive Drug Development Plan: Strategic Planning through the Product Lifecycle & S5 : Creating Comprehensive Drug Development Plan
13:30~15:00 S2 : Creating Comprehensive Drug Development Plan: Strategic Planning through the Product Lifecycle Chair : Mi-Young Bahng,
Jungshin Park
13:30~14:00 Begin with end in mind: Target product profile and clinical development plan Nari Yun GI-Innovation
14:00~14:30 Orphan Drug and Expedited Drug Development Programs in US/EU Hye Jin Choi IQVIA
14:30~15:00 Global & Market Expansion of K-CAB Eunji Kim HK inno.N
15:00~15:30 Coffee Break
15:30~17:00 S5 : Creating Comprehensive Drug Development Plan: Strategic Planning through Multifunctional Integration Chair : Myunghoon Kim,
Sora Lee
15:30~15:50 Market Segmentation And Multi-Indication Approach Seung-Won Jeong Hanall Bio
15:50~16:10 Clinical Trial Design for Regulatory and Commercial Success Miyoung Kim LG Chemical Life Sciences
16:10~16:30 Biostatistical Validation of Protocol for Clinical and Commercial Success Sang Joon Lee Celltrion
16:30~16:45 How to Incorporate Market Access Strategy to Clinical Trials Yuri Lee AMGEN
16:45~17:00 Q&A and Pannel Discussion
S3 : Understanding Market and Investment Theory & S6: Practical Investment Guide based on Real Cases
13:30~15:00 S3 : Understanding Market and Investment Theory Chair : Myungkee Kim
13:30~13:50 Global/Korean Life Science Investment Market Trend Min Sik Shin KB Investment
13:50~14:10 Selecting the Right Biotech Company to Invest Aleum Lee IMM Investment
14:10~14:30 Global Life Science Investment Fund Ted Moon RM Global
14:30~14:50 Healthcare Company IPO Trends & Technology Assessment Listing Track Strategies Wonje Kim Samsung Securities Co., Ltd
14:50~15:00 Q&A
15:30~17:00 S6 : Practical Investment Guide based on Real Cases Chair : Minsik Park
15:30~16:00 IPO by Technology Assessment Listing Jung-Sun Yum CHA Vaccine Institute
16:00~16:25 Listing Experiences in the KONEX & KOSDAQ - Genome & Company Youngjin Seo Genome & Company
16:25~16:50 IPO by Special Purpose Acquisition Company (SPAC) Kisub Lee Kainos Medicine
16:50~17:00 Q&A

up